Technical Briefing Seminar
on Essential Medicines Policies

Venue: WHO Headquarters, Geneva, Salle G (8th floor)

Dates: 19 September-23 September 2005

Key readings Draft Programme PPT Presentations



TBS home


Previous seminars

Application form



Briefing report


Monday 19 September 2005
(Facilitation: Richard Laing, Zafar Mirza, Jean-Marie Trapsida)



Salle G, Main building (8th floor)



Welcome - Objectives of the Seminar 
Hans Hogerzeil, Director PSM
Precious Matsoso, Director TCM




Introduction of participants: Gallery of experts 
Zafar Mirza, RA/EMRO
10.15-10.45 Coffee
10.45-11.00 Seminar overview and administration
Richard Laing, PSM/PAR
Lalit Dwivedi, PSM/PAR
11.00-12.30 PSM and TCM roles and responsibilities in implementing the WHO Medicines Strategy 

Hans Hogerzeil, Director PSM

PSM Strategic Direction 2006-2007

Precious Matsoso, Director TCM

TCM Strategic Direction and Competency Review

12.30-14.00 Lunch
National Drug Policies
14.00-14.30 National Medicines Policies 
Richard Laing, PSM/PAR
Hans Hogerzeil, Director PSM

National Medicines Policies

Selection of Essential Medicines
14.30-15.30 Update 2005 WHO Model List of Essential Medicines Selection, evidence-based approach 
Hans Hogerzeil, Director PSM

Selection of essential medicines

15.45-16.00 Tea
Information resources
16.00-17.00 Documentation Centre, Essential Medicines Library & Bookshelf, WHO Model Formulary 
Claude Da Re, TCM
Lalit Dwivedi, PSM/PAR

WHO EDM Documentation Centre

WHO Essential Medicines Library

17.30-19.00 Reception with Assistant Director General, WHO/HTP Cluster and PSM & TCM staff members 
(WHO Restaurant, Main Building)

Tuesday 20 September 2005
(Facilitation: Zafar Mirza)

Top of page
What is quality?
09.00-12.30 Medicine/Drug regulation and quality assurance WHO normative functions in the field of pharmaceuticals 
Lembit Rago, PSM/QSM

Assuring Quality, Safety, Efficacy of Drugs

Sabine Kopp, PSM/QSM

Drug Regulation and Quality Assurance: - WHO normative functions in the field of pharmaceuticals

Assessment of regulatory capacity at country level including 10 country study 
Valerio Reggi, PSM/QSM
Eshetu Wondemagegnehu, PSM/QSM

Strengthening National Drug Regulatory Capacity

10.45-11-00 Coffee
12.30-14.00 Lunch
14.00-15.30 Prequalification of essential medicines 
Lembit Rago, PSM/QSM
Olivier Gross, PSM/QSM





Global issues



Impact of globalization, international trade agreements, Doha, Cancun 
German Velásquez, Associate Director TCM
Cecilia Oh, TCM/DAP

Trade, TRIPS and access to medicines

Wednesday 21 September 2005
(Facilitation: Richard Laing)

Top of page
What is access?
09.00-11.30 Access framework, HIV/AIDS, TB and Malaria
Clive Ondari, PSM/PAR

Access to Antimalarials

Marthe Everard, PSM/PAR

Access to Essential Medicines

Helen Tata, TCM/DAP
Peter Graaff, WHO/HIV
Paul Matiru, GDF-TB


Murtada Sesay, UNICEF


Luca Di Bassi, Global Fund for AIDS, TB and Malaria
Short presentations + Panel discussion
10.30-10.45 Coffee
11.30-12.30 Essential Medicines as a Human Right
Hans Hogerzeil, Director PSM

Ruling for access



Medicine Prices and Financing
14.00-15.45 Medicine prices, WHO/NGO Price Survey Methodology
Richard Laing, PSM/PAR
Gilles Forte, TCM/DAP

The prices of medicines measurement methodology and findings in countries

15.45-16.00 Tea
Medicines promotion
16.00-17.30 Hot Topics 
(to be revised based on participant interest) 
Key issues in access and best practices: MDGs; private sector (OTC/prescriptions); human resources; medical education curricula; medicines promotion and ethical criteria; special needs in small countries


Richard Laing, PSM/PAR
Zafar Mirza, RA/EMRO
Guitelle Baghdadi, PSM/PAR

Drug promotion

Pramod Samantaray, UNFPA Consultant (Trg) & National Consultant, India

Medicines Promotion/Key intervention in Access and client friendly Health care delivery in India



Dinner, Geneva
(Optional: all have to pay for themselves: sorry!)

Thursday 22 September 2005
(Facilitation: Jean-Marie Trapsida)

Top of page
Country programmes
09.00-09.30 WHO Strategy for working with and in countries
Gilles Forte, TCM/DAP
Technical cooperation with countries
09.30-10.45 TCM strategy for working with countries - regional and country perspective 
Jean-Marie Trapsida, WHO/AFRO
TCM Team
WHO strategy for working with countries: Regional and country perspective



EDM strategy for working with countries - the experience of Kenya
Helen Tata, TCM/DAP

Evaluation and Monitoring of Country Implementation of Work: Addressing Common Problems
Regina Mbindyo, WHO/AFRO WHO Medicines Work in Countries: The Kenya Example



Indicators on pharmaceutical situations
Daisy Carandang, TCM/DAP

Using indicators to measure country pharmaceutical situations


Traditional Medicine



International harmonization focus on the regulatory requirements for quality and safety of herbal medicines
Samvel Azatyan, TCM/TRM

Traditional Medicine

Friday 23 September 2005
(Facilitation: Richard Laing)

Top of page


Pharmacovigilance: New challenges for WHO
Mary Couper, PSM/QSM
Shanthi Pal, PSM/QSM
What is rational medicine use?


Promoting rational medicine
Kathleen Holloway, PSM/PAR
Rational Use of Drugs: an Overview



12.30 Closure
14.00 Additional time for sessions, individual appointments with TCM/PSM staff